TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
VERA

Vera Therapeutics Inc

Healthcare · Biotechnology

33.10$ -8.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement VERA
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – -100.0% –
– -50.7% -29.9% -580.7% – – -78.4%
– – – – +120.1% -216.5% –
– +502.4% -48.8% +206.9% +13.4% +61.3% +70.6%
– -8.4% +195.1% +83.8% +8.6% +72.4% +144.4%
– +308.6% -28.0% +164.2% +12.2% +63.9% +88.7%
– – – – – – –
– +225.5% -88.0% +4,860.0% +281.7% +101.4% -1.2%
– – – – – – –
– +0.0% +0.0% +0.0% +0.0% +0.0% +0.0%
– – – – – – –
– – – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?